ACIP Recommendations: Orthopoxviruses (Smallpox and Mpox) Vaccines

Key points

  • The Advisory Committee on Immunization Practices (ACIP) develops recommendations on how to use vaccines to control disease in the United States.
  • These recommendations become official CDC policy once adopted by CDC's Director.
  • Learn about current and historical ACIP recommendations for Orthopoxviruses (Smallpox and Mpox) vaccines.

Published in Morbidity and Mortality Weekly Report (MMWR)

The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).

ARCHIVED historical Smallpox and Mpox immunization publications

For your convenience, these archived publications can be used for historical and research purposes.

MMWR, April 4, 2003, Vol 52(13);282-284
Notice to Readers: Supplemental Recommendations on Adverse Events Following Smallpox Vaccine in the Pre-Event Vaccination Program: Recommendations of the ACIP
Print version

MMWR
, March 21, 2003, Vol 52(12);256
Notice to Readers: National Smallpox Vaccine in Pregnancy Registry
Print version

MMWR
, February 21, 2003, Vol 52(RR-04);1-28
Smallpox Vaccination and Adverse Reactions: Guidance for Clinicians
Print version

Related pages

Petersen BW, Damon IK, Pertowski CA, Meaney-Delman D, Guarnizo JT, Beigi RH, et al. Clinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program MMWR. 2015;64(RR02);1-26.